Evidence map›Paper›PMID 32041352›Full record

ArticlePathogens (Basel, Switzerland)2020

High Prevalence of

Elinor Chloe Baker, Damien K Ming, Yasmin Choudhury, Shahedur Rahman, Philip J Smith, Jose Muñoz, Peter L Chiodini, Chris J Griffiths, Christopher Jm Whitty, Michael Brown

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Elinor Chloe BakerWhipps Cross University Hospital, London E11 1NR, UK.
Damien K MingHospital for Tropical Diseases, University College London Hospitals, London WC1E 6JB, UK.
Yasmin ChoudhuryWilliam Harvey Heart Centre, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Shahedur RahmanRiverside Medical Centre, Hockley SS5 6JY, UK.
Philip J SmithRoyal Liverpool University Hospital, Liverpool L7 8XP, UK.
Jose MuñozBarcelona Centre for International Health Research, 08014 Barcelona, Spain.
Peter L ChiodiniHospital for Tropical Diseases, University College London Hospitals, London WC1E 6JB, UK.
Chris J GriffithsInstitute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.
Christopher Jm WhittyHospital for Tropical Diseases, University College London Hospitals, London WC1E 6JB, UK.
Michael BrownHospital for Tropical Diseases, University College London Hospitals, London WC1E 6JB, UK.
Queen Mary University of London · GBRoyal London Hospital · GBUniversity of London · GBBarcelona Centre for International Affairs · ESRiverside · GBUniversity of Liverpool · GBWhipps Cross University Hospital · GB

Funding

Medical Research Council G0902022
6 · The paper itself

Abstract

Gastrointestinal (GI) symptoms are a frequent reason for primary care consultation, and common amongst patients with strongyloidiasis. We conducted a prospective cohort and nested case control study in East London to examine the predictive value of a raised eosinophil count or of GI symptoms, for

Indexed as

eosinophiliagastrointestinal symptomsivermectinmigrant healthprimary careStrongyloides

Identifiers

PMID32041352
PMCPMC7168230
OpenAlexW3005081717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.